Stay updated with breaking news from High Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wall Street analysts expect Amedisys, Inc. (NASDAQ:AMED – Get Rating) to post $1.24 earnings per share for the current fiscal quarter, according to Zacks. Eight analysts have made estimates for Amedisys’ earnings, with the lowest EPS estimate coming in at $1.19 and the highest estimate coming in at $1.31. Amedisys reported earnings of $1.69 per […]
Shares of Amedisys, Inc. (NASDAQ:AMED – Get Rating) have been given an average recommendation of “Buy” by the eighteen brokerages that are presently covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12-month price target among […]
Amedisys (NASDAQ:AMED – Get Rating) posted its quarterly earnings results on Wednesday. The health services provider reported $1.23 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.12 by $0.11, MarketWatch Earnings reports. Amedisys had a net margin of 9.44% and a return on equity of 21.84%. During the same quarter in […]
Wall Street brokerages expect Amedisys, Inc. (NASDAQ:AMED – Get Rating) to post $557.81 million in sales for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have made estimates for Amedisys’ earnings, with the highest sales estimate coming in at $569.00 million and the lowest estimate coming in at $548.85 million. Amedisys reported […]
Jefferies Financial Group restated their buy rating on shares of Amedisys (NASDAQ:AMED – Get Rating) in a report published on Thursday morning. The firm currently has a $200.00 price objective on the health services provider’s stock. Several other equities research analysts also recently weighed in on the stock. StockNews.com initiated coverage on shares of Amedisys […]